COMPARING CARDIOVASCULAR EVENT RATES OF STATIN PLUS FIBRATE COMBINATION THERAPY WITH STATIN MONOTHERAPY IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS

被引：0

作者：

Suh, H. S. ^{[1
]}

Doctor, J. N. ^{[1
]}

机构：

[1] Univ So Calif, Los Angeles, CA USA

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)73770-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A141 / A142

页数：2

共 50 条

[1] COMPARISON OF CARDIOVASCULAR EVENT RATES IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS WHO AUGMENTED FROM STATIN MONOTHERAPY TO STATIN PLUS FIBRATE COMBINATION THERAPY WITH THOSE WHO REMAINED ON STATIN MONOTHERAPY
Suh, H. S.
Doctor, J. N.
VALUE IN HEALTH, 2009, 12 (03) : A7 - A7
[2] DEALING WITH SELECTION BIAS IN NONLINEAR SETTINGS: A CASE OF COMPARATIVE EFFECTIVENESS OF STATIN PLUS FIBRATE COMBINATION THERAPY VERSUS STATIN MONOTHERAPY IN TYPE II DIABETES
Suh, H. S.
Doctor, J.
Hay, J. V. V.
VALUE IN HEALTH, 2010, 13 (03) : A8 - A8
[3] Combination statin and fibrate therapy in type 2 diabetes: Results from the lipids in diabetes study
Neil, A
Wheeler, F
Cull, C
Manley, S
Keenan, J
Holman, R
DIABETES, 2003, 52 : A74 - A74
[4] Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus
Reyes-Soffer, Gissette
Rondon-Clavo, Carlos
Ginsberg, Henry N.
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (09) : 1429 - 1438
[5] Statin-fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low
Athyros, Vasilios G.
Wierzbicki, Anthony S.
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 57 - 58
[6] Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias
Suh, Hae Sun
Hay, Joel W.
Johnson, Kathleen A.
Doctor, Jason N.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (05) : 470 - 484
[7] REAL-WORLD EVIDENCE ON THE EFFECTS OF STATIN-FIBRATE COMBINATION THERAPY IN TYPE-2 DIABETES: THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) TRIAL REDUX
Borah, B. J.
Shah, N.
Reinalda, M.
Montori, V
VALUE IN HEALTH, 2012, 15 (04) : A3 - A3
[8] Statin and Fibrate Combination Does not Additionally Lower Plasma Cholesteryl Ester Transfer in Type 2 Diabetes Mellitus
de Vries, Rindert
Dikkeschei, Bert D.
Sluiter, Wim J.
Dallinga-Thie, Geesje M.
van Tol, Arie
Dullaart, Robin P. F.
CLINICAL LABORATORY, 2012, 58 (11-12) : 1231 - 1239
[9] Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?
Rosenblit, Paul D.
CURRENT CARDIOLOGY REPORTS, 2012, 14 (01) : 112 - 124
[10] Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?
Paul D. Rosenblit
Current Cardiology Reports, 2012, 14 : 112 - 124

← 1 2 3 4 5 →